LP-108
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LP-108, covering 2026-01-23 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML [Phase 1]